Boston, US, New Haven, US & Guildford, UK, February 8, 2017 – Today, IDBS, a leading global provider of advanced software for R&D companies, announced that New Haven-based Achillion Pharmaceuticals has implemented the IDBS E-WorkBook for electronic laboratory data capture.
Atul Agarwal, Executive Director at Achillion, said: “IDBS was a standout choice of electronic laboratory notebook (ELN) provider because of its forward-thinking vision, flexibility and first-class customer service. We were looking for a provider with the ability to scale-up as we continue to grow and bring new therapeutics to trial, and IDBS has the agility and openness to do so.”
Using the IDBS E-WorkBook platform will help Achillion improve data capture, knowledge sharing and management across multiple sites.
Ian Peirson, Head of Product Planning at IDBS, said: “IDBS is proud to support Achillion’s noble objective of discovering, developing and marketing new treatments for diseases. It is inspiring to know that E-WorkBook and the Chemistry module will play a part in helping Achillion to achieve its objectives.”
The E-WorkBook platform will give Achillion scientists a clear and intuitive interface to work with whilst synthesising and testing new discovery compounds.
IDBS’ strategic partnership with ChemAxon also provides Achillion with world-leading technology for the robust representations of chemical and biological molecules, enabling Achillion scientists to ensure their data is stored in a modern and industry-standard data format.
Furthermore, IDBS’ ability to provide a combination of secure on-premise and SaaS solutions cemented Achillion’s decision to transition to a 100% electronic laboratory notebook with IDBS.